Medications

Awareness of, referral to HIV PrEP low among Hispanics

(HealthDay)—About one in four Hispanic persons tested for HIV are aware of preexposure prophylaxis (PrEP) and about one in five of those eligible for referral are referred to PrEP providers, according to research published ...

HIV & AIDS

Impaired T cell function precedes loss of natural HIV control

HIV is a master of evading the immune system, using a variety of methods to prevent the body from being able to find and kill it. The vast majority of people living with HIV require daily medication to suppress the virus ...

HIV & AIDS

HIV linked with increased risk of sudden cardiac death

People living with human immunodeficiency virus (HIV) have a higher risk of sudden cardiac death than people who do not have HIV, especially if the virus is not well-controlled or if they have other heart disease risk factors, ...

Medications

Cabotegravir bests TDF-FTC for HIV prevention in those at risk

(HealthDay)—For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine ...

HIV & AIDS

Is it possible to deliver a knockout punch to HIV?

With a global focus on strategies to curb expansion of a fast-moving coronavirus pandemic, the question again has arisen: What more is being done about HIV, a scourge that has lasted more than 40 years—is a cure finally ...

page 17 from 40